Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteers



Ball, Amy L, Bloch, Katarzyna M, Rainbow, Lucille ORCID: 0000-0003-0447-6885, Liu, Xuan, Kenny, John, Lyon, Jonathan J, Gregory, Richard, Alfirevic, Ana ORCID: 0000-0002-2801-9817 and Chadwick, Amy E ORCID: 0000-0002-7399-8655
(2021) Assessment of the impact of mitochondrial genotype upon drug-induced mitochondrial dysfunction in platelets derived from healthy volunteers. Archives of Toxicology.

Access the full-text of this item by clicking on the Open Access link.

Abstract

<jats:title>Abstract</jats:title><jats:p>Mitochondrial DNA (mtDNA) is highly polymorphic and encodes 13 proteins which are critical to the production of ATP via oxidative phosphorylation. As mtDNA is maternally inherited and undergoes negligible recombination, acquired mutations have subdivided the human population into several discrete haplogroups. Mitochondrial haplogroup has been found to significantly alter mitochondrial function and impact susceptibility to adverse drug reactions. Despite these findings, there are currently limited models to assess the effect of mtDNA variation upon susceptibility to adverse drug reactions. Platelets offer a potential personalised model of this variation, as their anucleate nature offers a source of mtDNA without interference from the nuclear genome. This study, therefore, aimed to determine the effect of mtDNA variation upon mitochondrial function and drug-induced mitochondrial dysfunction in a platelet model. The mtDNA haplogroup of 383 healthy volunteers was determined using next-generation mtDNA sequencing (Illumina MiSeq). Subsequently, 30 of these volunteers from mitochondrial haplogroups <jats:italic>H</jats:italic>, <jats:italic>J</jats:italic>, <jats:italic>T</jats:italic> and <jats:italic>U</jats:italic> were recalled to donate fresh, whole blood from which platelets were isolated. Platelet mitochondrial function was tested at basal state and upon treatment with compounds associated with both mitochondrial dysfunction and adverse drug reactions, flutamide, 2-hydroxyflutamide and tolcapone (10–250 μM) using extracellular flux analysis. This study has demonstrated that freshly-isolated platelets are a practical, primary cell model, which is amenable to the study of drug-induced mitochondrial dysfunction. Specifically, platelets from donors of haplogroup <jats:italic>J</jats:italic> have been found to have increased susceptibility to the inhibition of complex I-driven respiration by 2-hydroxyflutamide. At a time when individual susceptibility to adverse drug reactions is not fully understood, this study provides evidence that inter-individual variation in mitochondrial genotype could be a factor in determining sensitivity to mitochondrial toxicants associated with costly adverse drug reactions.</jats:p>

Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 18 Feb 2021 09:14
Last Modified: 04 Oct 2021 16:10
DOI: 10.1007/s00204-021-02988-3
Open Access URL: https://doi.org/10.1007/s00204-021-02988-3
URI: https://livrepository.liverpool.ac.uk/id/eprint/3115801